AMLX · Amylyx Pharmaceuticals, Inc. · Executive Compensation

$29.03 +0.26 (+0.90%) At close · Oct 21

Russell 2000 member Rebalance outlook locked

Market Cap

$3.28B

111.42M

Volume · Oct 21 1.63M Avg daily vol (3M) 2.31M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joshua Cohen	Co-Chief Executive Officer and Director	$686,200	—	$650,226	$817,783	$548,098	$17,500	$2,719,807
Justin Klee	Co-Chief Executive Officer and Director	$686,200	—	$650,226	$817,783	$548,098	$17,500	$2,719,807
Camille Bedrosian	Chief Medical Officer	$575,000	—	$246,996	$312,872	$275,569	$157,237	$1,567,674
James Frates	Chief Financial Officer	$540,600	—	$246,996	$311,148	$259,083	$17,500	$1,375,327

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joshua Cohen	Co-Chief Executive Officer and Director	$686,200	—	$2,585,771	$2,685,179	$521,855	$17,250	$6,496,255
Justin Klee	Co-Chief Executive Officer and Director	$686,200	—	$2,585,771	$2,685,179	$521,855	$17,250	$6,496,255
James Frates	Chief Financial Officer	$540,600	—	$885,672	$848,404	$248,427	$17,250	$2,540,353
Gina M. Mazzariello	Chief Legal Officer and General Counsel	$478,400	—	$805,798	$777,704	$219,844	$17,250	$2,298,996

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joshua Cohen	Co-Chief Executive Officer and Director	$621,000	—	$1,604,000	$4,733,928	$447,741	$11,500	$7,418,169
Justin Klee	Co-Chief Executive Officer and Director	$621,000	—	$1,604,000	$4,733,928	$447,741	$11,500	$7,418,169
James Frates	Chief Financial Officer	$510,000	—	$695,077	$2,052,137	$241,663	$11,500	$3,510,377
Margaret Olinger	Former Chief Commercial Officer	$488,750	—	$618,194	$1,736,927	$225,216	$378,063	$3,447,150
Gina M. Mazzariello	Chief Legal Officer and General Counsel	$460,000	—	$588,123	$1,736,288	$217,765	$11,500	$3,013,676
Camille Bedrosian	Chief Medical Officer	$56,763	$173,000	$754,246	$1,386,012	—	$2,838	$2,372,859

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Justin Klee	Co-Chief Executive Officer and Director	$539,275	—	$1,425,000	$4,752,000	$452,991	$9,150	$7,178,416
Joshua Cohen	Co-Chief Executive Officer and Director	$539,275	—	$1,425,000	$4,752,000	$452,991	$9,150	$7,178,416
Gina M. Mazzariello	Chief Legal Officer and General Counsel	$342,593	$250,000	$1,229,180	$4,089,540	$193,085	$9,150	$6,113,548
James Frates	Chief Financial Officer	$439,500	—	$601,673	$2,362,150	$246,472	$9,150	$3,658,945
Margaret Olinger	Former Chief Commercial Officer	$424,337	—	$538,327	$1,795,200	$228,803	$9,150	$2,995,817

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
James Frates	Chief Financial Officer	$375,000	$615,000	—	$2,052,080	$205,120	$8,700	$3,255,900
Justin Klee	Co-Chief Executive Officer and Director	$417,833	—	—	$698,000	$300,000	$8,700	$1,424,533
Joshua Cohen	Co-Chief Executive Officer and Director	$417,833	—	—	$698,000	$300,000	$8,700	$1,424,533
Margaret Olinger	Former Chief Commercial Officer	$372,000	—	—	$296,400	$186,298	$8,700	$863,398

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joshua Cohen	Co-Chief Executive officer and Director	$370,000	—	—	$97,000	$203,500	—	$670,500
Justin Klee	Co-Chief Executive Officer and Director	$370,000	—	—	$97,000	$203,500	—	$670,500
Margaret Olinger	Chief Commercial Officer	$360,200	—	—	—	$154,836	—	$515,036

Executive changes

Person	Role	Change	Effective	Filed
Bernhardt Zeiher	Class I director	Appointed	2024-03-14	2024-03-14
Karen Firestone	Class I director	Appointed	2023-03-16	2023-03-21
Isaac Cheng, MD	member of the board of directors	Resigned	2022-11-01	2022-11-02

Leadership

Joshua Cohen CEO, Board Member
Justin Klee CEO, Board Member
James Frates CFO
Gina M. Mazzariello General Counsel
George Mclean Milne Jr Board Member
Paul Fonteyne Board Member

Key facts CIK 1658551 CUSIP 03237H101 13F (30d) 17 filings 17 filers Visit website Investor relations